Terminated PHASE3 INTERVENTIONAL 2-arm NCT01833312

Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke (EuroHYP-1)

EuroHYP-1: European Multicentre, Randomised, Phase III Clinical Trial of Therapeutic Hypothermia Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke

Sponsor: University of Erlangen-Nürnberg Medical School

Conditions Acute Ischemic Stroke

Interventions Buspirone Hypothermia Pethidine

Updated 7 times since 2017 Last updated: Sep 30, 2019 Started: Jul 31, 2013 Primary completion: Jul 31, 2018 Completion: Jul 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow recruitment, cessation of funding

This PHASE3 trial investigates Acute Ischemic Stroke and is currently terminated or withdrawn. University of Erlangen-Nürnberg Medical School leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE3
Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Nov 2019 — Jan 2021 [monthly]

Terminated PHASE3

Status: Recruiting → Terminated

▶ Show 2 earlier versions

Jun 2018 — Nov 2019 [monthly]

Recruiting PHASE3
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Erlangen-Nürnberg Medical School

Data source: University of Erlangen-Nürnberg Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Erlangen, Germany